dc.contributor.author | Ok, Engin | |
dc.contributor.author | Saip, Pinar | |
dc.contributor.author | Uras, Cihan | |
dc.contributor.author | Demircan, Orhan | |
dc.contributor.author | Isikdogan, Abdurrahman | |
dc.contributor.author | Ozmen, Vahit | |
dc.contributor.author | Atasoy, Ajlan | |
dc.contributor.author | Gökmen, Erhan | |
dc.contributor.author | Ozdogan, Mustafa | |
dc.contributor.author | Guler, Nilufer | |
dc.date.accessioned | 2021-03-04T13:31:29Z | |
dc.date.available | 2021-03-04T13:31:29Z | |
dc.identifier.citation | Ozmen V., Atasoy A., Gökmen E., Ozdogan M., Guler N., Uras C., Ok E., Demircan O., Isikdogan A., Saip P., "Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey", CUREUS, cilt.8, 2016 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_7cd5cc3a-6e2f-47ec-a24f-c5a854f6d16c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/85356 | |
dc.identifier.uri | https://doi.org/10.7759/cureus.522 | |
dc.description.abstract | Introduction: Breast cancer is the most common malignancy among Turkish women and the rate of early stage disease is increasing. The Oncotype DX (R) 21-gene assay is predictive of distant recurrence in ER-positive, HER2-negative early breast cancer. We aimed to evaluate the impact of the Recurrence Score (R) (RS) on treatment decisions and physician perceptions in Turkey. We also studied correlations between RS and routine risk factors. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey | |
dc.type | Makale | |
dc.relation.journal | CUREUS | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Cerrahi | |
dc.identifier.volume | 8 | |
dc.contributor.firstauthorID | 2503164 | |